GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Sito Bio-technology Co Ltd (SZSE:300583) » Definitions » ROE %

Shandong Sito Bio-technology Co (SZSE:300583) ROE % : 0.61% (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Shandong Sito Bio-technology Co ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Shandong Sito Bio-technology Co's annualized net income for the quarter that ended in Mar. 2024 was ¥12 Mil. Shandong Sito Bio-technology Co's average Total Stockholders Equity over the quarter that ended in Mar. 2024 was ¥2,014 Mil. Therefore, Shandong Sito Bio-technology Co's annualized ROE % for the quarter that ended in Mar. 2024 was 0.61%.

The historical rank and industry rank for Shandong Sito Bio-technology Co's ROE % or its related term are showing as below:

SZSE:300583' s ROE % Range Over the Past 10 Years
Min: -10.35   Med: 4.99   Max: 85.08
Current: 1.7

During the past 12 years, Shandong Sito Bio-technology Co's highest ROE % was 85.08%. The lowest was -10.35%. And the median was 4.99%.

SZSE:300583's ROE % is ranked better than
82.8% of 1349 companies
in the Biotechnology industry
Industry Median: -43.73 vs SZSE:300583: 1.70

Shandong Sito Bio-technology Co ROE % Historical Data

The historical data trend for Shandong Sito Bio-technology Co's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Sito Bio-technology Co ROE % Chart

Shandong Sito Bio-technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.96 -10.35 2.18 2.47 2.44

Shandong Sito Bio-technology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.56 9.49 0.23 -3.08 0.61

Competitive Comparison of Shandong Sito Bio-technology Co's ROE %

For the Biotechnology subindustry, Shandong Sito Bio-technology Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Sito Bio-technology Co's ROE % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shandong Sito Bio-technology Co's ROE % distribution charts can be found below:

* The bar in red indicates where Shandong Sito Bio-technology Co's ROE % falls into.



Shandong Sito Bio-technology Co ROE % Calculation

Shandong Sito Bio-technology Co's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=45.604/( (1720.137+2012.157)/ 2 )
=45.604/1866.147
=2.44 %

Shandong Sito Bio-technology Co's annualized ROE % for the quarter that ended in Mar. 2024 is calculated as

ROE %=Net Income (Q: Mar. 2024 )/( (Total Stockholders Equity (Q: Dec. 2023 )+Total Stockholders Equity (Q: Mar. 2024 ))/ count )
=12.284/( (2012.157+2016.12)/ 2 )
=12.284/2014.1385
=0.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2024) net income data. ROE % is displayed in the 30-year financial page.


Shandong Sito Bio-technology Co  (SZSE:300583) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=12.284/2014.1385
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(12.284 / 977.584)*(977.584 / 3305.1645)*(3305.1645 / 2014.1385)
=Net Margin %*Asset Turnover*Equity Multiplier
=1.26 %*0.2958*1.641
=ROA %*Equity Multiplier
=0.37 %*1.641
=0.61 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=12.284/2014.1385
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (12.284 / 32.324) * (32.324 / 77.88) * (77.88 / 977.584) * (977.584 / 3305.1645) * (3305.1645 / 2014.1385)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.38 * 0.415 * 7.97 % * 0.2958 * 1.641
=0.61 %

Note: The net income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Shandong Sito Bio-technology Co ROE % Related Terms

Thank you for viewing the detailed overview of Shandong Sito Bio-technology Co's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Sito Bio-technology Co (SZSE:300583) Business Description

Traded in Other Exchanges
N/A
Address
South Section of East Outer Ring Road, Dingtao County, Shandong Province, Heze, CHN, 274000
Shandong Sito Bio-technology Co Ltd is a biotechnology company. It is specialized in the research and development and production of core derivatives and derivatives of new steroid hormone drugs. The company offers bio-steroidal drug raw materials such as androstenedione, nonhydroxyandrostenedione and androstenedione.
Executives
Mi Qi Directors, executives
Wang Min Director
Kong Qing Zhi Executives
He Jian Yong Directors, executives
Ceng Qing Li Securities Affairs Representative

Shandong Sito Bio-technology Co (SZSE:300583) Headlines

No Headlines